Skip to content

R&D at other companies

Guardant Health logo
Guardant HealthGH
$91.04M+2.8%
Natera, Inc. logo
Natera, Inc.NTRA
$210.7M+63.2%
Revvity logo
RevvityRVTY
$57.89M+8.0%
Agilent Technologies logo
Agilent TechnologiesA
$126M+12.5%
TEC
Bio-TechneTECH
$23.46M-4.6%
Danaher logo
DanaherDHR
$387M+2.1%

Other financials

Income statement

See full
Revenue$348.1M+36.1%
Operating income-$84.7M-23.3%
Net income-$125.9M-85.1%
EPS (diluted)-$0.71-77.5%

Balance sheet

See full
Cash & equivalents$525.9M+243%
Total debt$85.4M+49.8%
Total equity$416.4M+27.7%
Total assets$2.1B+38.4%

Cash flow

See full
Operating cash flow-$73.3M+30.6%
CapEx$8.2M+295%
Free cash flow-$81.5M+24.3%

Valuation

See full
Market cap$9.13B-2.7%
Enterprise value$8.69B-6.9%
P/S6.7×-5.0×

Profitability

See full
Operating margin-19.7%-8.6pp
Net margin-22.2%-9.5pp
FCF margin-54.5%

Returns & leverage

See full
Return on equity-81.6%
Debt / equity0.2×0.0×
Current ratio3.3×+1.6×

Where this comes from

Reported directly by Tempus AI, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The official record: Tempus AI, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Tempus AI, Inc.'s r&d.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Tempus AI, Inc.'s R&D?
Tempus AI, Inc. (TEM) reported R&D of $48.24M in Q1 2026.
How has Tempus AI, Inc.'s R&D changed year-over-year?
Tempus AI, Inc.'s R&D increased by 34.5% year-over-year, from $35.87M to $48.24M.
What is the long-term trend for Tempus AI, Inc.'s R&D?
Over 3 years (2022 to 2025), Tempus AI, Inc.'s R&D has grown at a 27.6% compound annual growth rate (CAGR), from $83.16M to $172.92M.
What does R&D mean?
Spending on the creation and improvement of products, services, and technologies.
How do you interpret R&D?
Increasing R&D often signals a commitment to future growth, whereas declining R&D may suggest a focus on short-term profitability.
How does R&D compare across companies?
Standard operating expense line item; essential for benchmarking innovation intensity against industry peers.